Effects of selected bioactive natural products on the vascular endothelium

Journal of Cardiovascular Pharmacology

Volumn 62, Issue 2, 2013, Pages 111-121

  Ahmad, Ajaz ^a   Khan, Rao M A ^a   Alkharfy, Khalid M ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Allium sativum; Camellia sinensis; Crataegus; endothelium; Medicinal plants; Nigella sativa; vasodilation; Vitis labrusca

Indexed keywords

ALLICIN; CRATAEGUS EXTRACT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELPHINIDIN; EPIGALLOCATECHIN GALLATE; MYRICETIN; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE; THROMBOXANE A2; THYMOQUINONE; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; BLACK CUMIN; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EFFECT; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; GARLIC; GRAPE JUICE; HEART HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HYPEREMIA; IN VITRO STUDY; LIPID PEROXIDATION; LUNG VASOCONSTRICTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RISK FACTOR; SHEAR STRESS; SMOOTH MUSCLE RELAXATION; SYSTOLIC BLOOD PRESSURE; TEA; THROMBOCYTE AGGREGATION; UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BIOLOGICAL PRODUCTS; CARDIOVASCULAR AGENTS; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; PHYTOTHERAPY; PLANT EXTRACTS; VASCULAR DISEASES;

EID: 84883272449     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182927e47     Document Type: Article

References (160)

1. Feletou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291:H985-H1002.
2. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994;269:13725-13728.
3. Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: Potential implications for pharmacotherapy. Drugs Aging. 2003;20: 527-550.
4. Shi Y, Ku DD, Man RY, et al. Augmented EDHF-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J Pharmacol Exp Ther. 2006; 318:276-281.
5. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996;28:703-711.
6. Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarizing factors and associated pathways: A synopsis. Pflugers Arch. 2010;459:17.
7. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the agerelated decline in women. J Am Coll Cardiol. 1994;24:471-476.
8. Kung CF, Luscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 1995;25:194-200.
9. Hongo K, Nakagomi T, Kassell NF, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 1988;19:892-897.
10. Atkinson J, Tatchum-Talom R, Corman B. Effect of chronic ANG I-converting enzyme inhibition on aging processes. III. Endothelial function of mesenteric arterial bed of rat. Am J Physiol. 1994;267(Pt 2):R136-R143.
11. Flammer AJ, Anderson T, Celemajer DS, et al. The assessment of endothelial function: From research into clinical practice. Circulation. 2012;126:753-767.
12. Vanhoutte PM, Shimokawa H, Tang EH, et al. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193-222.
13. Hamilton CA, Brosnan MJ, McIntyre M, et al. Superoxide excess in hypertension and aging: A common cause of endothelial dysfunction. Hypertension. 2001;37:6.
14. Taddei S, Virdis A, Ghiadoni L, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:6.
15. van der Loo B, Labuggerb R, Skepper JN, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:14.
16. Aranda R, Domenech E, Rus AD. Age-related increase in xanthine oxidase activity in human plasma and rat tissues. Free Radic Res. 2007;41:1195-1200.
17. Langleben D, Dupuis J, Langleben I, et al. Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. Chest. 2006;129:689-695.
18. Kansui Y, Fujii K, Goto K, et al. Angiotensin II receptor antagonist improves age-related endothelial dysfunction. J Hypertens. 2002;20:439-446.
19. Dal-Ros S, Bronner C, Schott C, et al. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. J Pharmacol Exp Ther. 2009;328:478-486.
20. Dattner AM. From medical herbalism to phytotherapy in dermatology: Back to the future. Dermatol Ther. 2003;16:106-113.
21. Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther. 2002;1:287-293; discussion 293.
22. Rege NN, Thatte UM, Dahanukar SA, Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res. 1999;13: 275-291.
23. Thatte UM, Kulkarni MR, Dahanukar SA. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia. J Postgrad Med. 1992;38:13-15.
24. Salem ML, Hossain MS. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol. 2000;22:729-740.
25. Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317-333.
26. Rahman I, Biswas SK, Kirkham PA, Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006;72: 1439-1452.
27. Dauchet L, Amouyel P, Herzog S, et al. Fruit and vegetable consumption and risk of coronary heart disease: A meta-Analysis of cohort studies. J Nutr. 2006;136:2588-2593.
28. Hertog MG, Hollman PC, Katan MB, et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 1993;20:21-29.
29. Knekt P, Jarvinen R, Reunanen A, et al. Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ. 1996;312:478-481.
30. Yochum L, Kushi LH, Meyer K, et al. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol. 1999;149:943-949.
31. Harbowy ME, Balentine DA. Tea chemistry. Crit Rev Plant Sci. 1983;16.
32. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and longterm risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155:381-386.
33. Sesso HD, Gaziano JM, Buring JE, et al. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol. 1999;149:162-167.
34. Geleijnse JM, Launer LJ, Hofman A, et al. Tea flavonoids may protect against atherosclerosis: The Rotterdam study. Arch Intern Med. 1999; 159:2170-2174.
35. Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125:384-389.
36. Morel I, Lescoat G, Cogrel P, et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on ironloaded rat hepatocyte cultures. Biochem Pharmacol. 1993;45:13-19.
37. Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-416.
38. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 1993;265:H774-H778.
39. Andriambeloson E, et al. Nitric oxide production and endotheliumdependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 1997;120:1053-1058.
40. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138:S419-S420.
41. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
42. Duffy SJ, Keaney JF Jr, Holbrook M, et al. Short-And long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151-156.
43. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26.
44. Gokce N, Keaney JF Jr, Frei B, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999;99:3234-3240.
45. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 1998;18:833-841.
46. van het Hof KH, Wiseman SA, Yang CS, et al. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med. 1999;220:203-209.
47. Yang CS, Kim S, Yang GY, et al. Inhibition of carcinogenesis by tea: Bioavailability of tea polyphenols and mechanisms of actions. Proc Soc Exp Biol Med. 1999;220:213-217.
48. Nagaya N, Yamamoto H, Uematsu M, et al. Green tea reverses endothelial dysfunction in healthy smokers. Heart. 2004;90:1485-1486.
49. Moore RJ, Jackson KG, Minihane AM. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr. 2009;102:1790-1802.
50. Miyazawa T. Absorption, metabolism and antioxidative effects of tea catechin in humans. Biofactors. 2000;13:55-59.
51. Lu H, Meng X, Li C, et al. Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities. Drug Metab Dispos. 2003;31:452-461.
52. Lambert JD, Rice JE, Hong J, et al. Synthesis and biological activity of the tea catechins metabolites, M4 and M6 and their methoxy-derivatives. Bioorg Med Chem Lett. 2005;15:873-876.
53. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693-696.
54. Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65:230-240.
55. Widlansky ME, Hamburg NM, Anter E, et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr. 2007;26:95-102.
56. Kim W, Jeong MH, Cho SH, et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J. 2006;70:1052-1057.
57. Tinahones FJ, Rubio MA, Garrido-Sanchez L, et al. Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr. 2008; 27:209-213.
58. Lee W, Min WK, Chun S, et al. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem. 2005; 38:84-87.
59. Rissanen TH, Voutilainen S, Virtanen JK, et al. Low intake of fruits, berries and vegetables is associated with excess mortality in men: The Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J Nutr. 2003;133:199-204.
60. Fung TT, Willet WC, Stampfer MJ, et al. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med. 2001;161:1857-1862.
61. Stein JH, Keevil JG, Wiebe DA, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999;100:1050-1055.
62. O?Byrne DJ, Devaraj S, Grundy SM, et al. Comparison of the antioxidant effects of concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr. 2002;76:1367-1374.
63. Chou EJ, Keevil JG, Aeschlimann S, et al. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol. 2001;88:553-555.
64. Flesch M, Schwarz A, Boehm M. Divergent effects of red and white wine on endothelium-dependent relaxation of human coronary arteries. Circulation. 1997;96:I-341. Abstract.
65. Negre-Salvayre A, Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic Biol Med. 1992;12:101-106.
66. Frankel EN, Waterhouse AL, Teissedra PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem. 1995;49:890-894.
67. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2004;22:169-188.
68. Russell JA, Rohrbach MS. Tannin induces endothelium-dependent contraction and relaxation of rabbit pulmonary artery. Am Rev Respir Dis. 1989;139:498-503.
69. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: A review. Clin Cardiol. 1997;20:426-432.
70. Sauter R, Folts JD, Freedman JE. Purple grape juice inhibits platelet function and increases platelet-derived nitric oxide release. Circulation. 1998;98:I-585. Abstract.
71. Stoclet JC, Kleschyov A, Andriambeloson E, et al. Endothelial no release caused by red wine polyphenols. J Physiol Pharmacol. 1999; 50:535-540. Abstract.
72. Stoclet JC, Chataigneau T, Ndiaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299-313.
73. Aldini G, Carini M, Piccoli A, et al. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: New evidences for cardio-protection. Life Sci. 2003;73:2883-2898.
74. Anselm E, Chataigneau M, Ndiaye M, et al. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src-And Akt-dependent activation of eNOS. Cardiovasc Res. 2007;73:404-413.
75. Agouni A, Lagrue0Lak-Hal A-H, Mostefai HA, et al. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One. 2009;4:e5557.
76. Blumenthal M. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council; 1998.
77. Anonymous. Monographs on the Medicinal Uses of Plants. Exeter, England: European Scientific Cooperative on Phytotherapy; 1997.
78. Schilcher H. Phytotherapy in Pediatrics: Handbook for Physicians and Pharmacists: With Reference to Commission E Monographs of the Federal Department of Health in Germany: Includes 100 Commission E Monographs and 15 ESCOP Monographs. Stuttgart, Germany: Medpharm Scientific Publishers; 1997:181.
79. Gorinstein S, Jastrzebski Z, Namiesnik J, et al. The atherosclerotic heart disease and protecting properties of garlic: Contemporary data. Mol Nutr Food Res. 2007;51:1365-1381.
80. Ali M, Al-Qattan KK, Al-Enezi F, et al. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids. 2000;62: 253-259.
81. Batirel HF, Naka Y, Kayano K, et al. Intravenous allicin improves pulmonary blood flow after ischemia-reperfusion injury in rats. J Cardiovasc Surg (Torino). 2002;43:175-179.
82. Steiner M, Khan AH, Holbert D, et al. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr. 1996;64:866-870.
83. Moller S, Burchardt H, Ogard CG, et al. Pulmonary blood volume and transit time in cirrhosis: Relation to lung function. Liver Int. 2006;26: 1072-1078.
84. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome- a liver-induced lung vascular disorder. N Engl J Med. 2008;358: 2378-2387.
85. De BK, Dutta D, Pal SK, et al. The role of garlic in hepatopulmonary syndrome: A randomized controlled trial. Can J Gastroenterol. 2010;24: 183-188.
86. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): A pilot trial. J Clin Gastroenterol. 1998;27: 232-235.
87. Williams MJ, Sutherland WH, McCormick MP, et al. Aged garlic extract improves endothelial function in men with coronary artery disease. Phytother Res. 2005;19:314-319.
88. Sun X, Ku D. Allicin in garlic protects against coronary endothelial dysfunction and right heart hypertrophy in pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol. 2006;291:H2431-H2438.
89. Baluchnejadmojarad T, Roghani M, Homayounfar H, et al. Beneficial effect of aqueous garlic extract on the vascular reactivity of streptozotocin-diabetic rats. J Ethnopharmacol. 2003;85:139-144.
90. Fallon MB, Abrams GA, Abdel-Razek TT, et al. Garlic prevents hypoxic pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol. 1998;275:283-287.
91. Kim-Park S, Ku DD. Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol. 2000;27:780-786.
92. Prasad K, Laxdal VA, Yu M, et al. Antioxidant activity of allicin, an active principle in garlic. Mol Cell Biochem. 1995;148:183-189.
93. Munday JS, James KA, Fray LM, et al. Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. Atherosclerosis. 1999;143:399-404.
94. Steiner M, Lin RS. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol. 1995;31:904-908.
95. Goreja WG. Black Seed: Nature?s Miracle Remedy. New York, NY: Amazing Herbs Press; 2003.
96. Junemann M. Three Great Healing Herbs. Twin Laked WI7 Lotus Light Publications; 1998.
97. Badary OA, Nagi MN, al-Shabanah OA, et al. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol. 1997;75:1356-1361.
98. Houghton PJ, Zarka R, de las Heras B, et al. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995;61:33-36.
99. Abdel-Fattah AM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol. 2000;400:89-97.
100. Hosseinzadeh H, Parvardeh S, Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine. 2004;11:56-64.
101. Marbut MM, Najdat Ali S, Al-Kadhi, et al. Extraction of flavonoid compounds from Nigella arvensis Linn seeds & to study their physiological effects on female reproductive system. Tikrit Med J. 2007;13: 64-69.
102. Merfort I, Wray V, Barakat HH, et al. Flavonol triglycosides from seeds of Nigella sativa. Phytochemistry. 1997;46:359-363.
103. Butt MS, Sultan MT. Nigella sativa: Reduces the risk of various maladies. Crit Rev Food Sci Nutr. 2010;50:654-665.
104. Tesarova H, Svobodova B, Kokoska L, et al. Determination of oxygen radical absorbance capacity of black cumin (Nigella sativa) seed quinone compounds. Nat Prod Commun. 2011;6:213-216.
105. Khattab MM, Nagi MN. Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother Res. 2007;21:410-414.
106. Suddek GM. Thymoquinone-induced relaxation of isolated rat pulmonary artery. J Ethnopharmacol. 2010;127:210-214.
107. Idris-Khodja N, Schini-Kerth V. Thymoquinone improves aging-related endothelial dysfunction in the rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:749-758.
108. Goto K, Fujii K, Kansui Y, et al. Changes in endothelium derived hyperpolarizing factor in hypertension and ageing: Response to chronic treatment with renin-Angiotensin system inhibitors. Clin Exp Pharmacol Physiol. 2004;31:650-655.
109. Brixius K, Willms S, Napp A, et al. Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther. 2006; 20:177-184.
110. Sainani GS, Maru VG. Role of endothelial cell dysfunction in essential hypertension. J Assoc Physicians India. 2004;52:966-969.
111. Zago AS, Zanesco A. Nitric oxide, cardiovascular disease and physical exercise. Arq Bras Cardiol. 2006;87:e264-e270.
112. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res. 2007;76:8-18.
113. Vita JA. Polyphenols and cardiovascular disease: Effects on endothelial and platelet function. Am J Clin Nutr. 2005;81(suppl 1):292S-297S.
114. Carr A, Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med. 2000;28:1806-1814.
115. Loke WM, Hodgson JM, Proudfoot JM, et al. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88:1018-1025.
116. Yamamoto Y, Oue E, Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem. 2006;70:933-939.
117. Moens AL, Goovaerts I, Claeys MJ, et al. Flow-mediated vasodilation: A diagnostic instrument, or an experimental tool? Chest. 2005;127: 2254-2263.
118. Duarte J, Perez-Vicaino F, Jiminez J, et al. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-Activity relationships. Gen Pharmacol. 1993;24:857-862.
119. Mizugaki M, Ishizawa F, Yamazaki T, et al. Epigallocatechin gallate increase the prostacyclin production of bovine aortic endothelial cells. Prostaglandins Other Lipid Mediat. 2000;62:157-164.
120. Suri S, Liu X-H, Rayment S, et al. Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol. 2010;159: 566-575.
121. Jackson SJ, Venema RC. Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J Nutr. 2006;136:1178-1184.
122. Ghigo D, Alessio P, Foco A, et al. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. Am J Physiol. 1993;265(Pt 1): C728-C732.
123. Martin S, Andriambeloson E, Takeda K, et al. Red wine polyphenols increase calcium in bovine aortic endothelial cells: A basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol. 2002;135:1579-1587.
124. Zhang H, Zhang J, Ungvari Z, et al. Resveratrol improves endothelial function: Role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol. 2009;29:1164-1171.
125. Gojkovic-Bukarica L, Novakovic A, Kanjuh V, et al. A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. J Pharmacol Sci. 2008;108:124-130.
126. Appeldoorn MM, Venema DP, Peters TH, et al. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J Agric Food Chem. 2009;57:7693-7699.
127. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med. 1994;16:845-850.
128. Wilms LC, Kleinjans JC, Moonen EJ, et al. Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro. Toxicol In Vitro. 2008;22:301-307.
129. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024-1029.
130. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: Effects of quercetin and wine polyphenols. Free Radic Res. 2006;40:1054-1065.
131. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol. 1999;33:248-254.
132. Auger C, Chaabi M, Anselm E, et al. The red wine extract-induced activation of endothelial nitric oxide synthase is mediated by a great variety of polyphenolic compounds. Mol Nutr Food Res. 2011;54:171-183.
133. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 2006;54:229-234.
134. Oyama J, M T, Kouzuma K, et al. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J. 2010;74:578-588.
135. Lopez-Sepulveda R, Gomez-Guzman M, Zarzuelo MJ, et al. Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: Role of NADPH oxidase. Clin Sci (Lond). 2011;120:321-333.
136. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens. 2001;14(Pt 2):83S-89S.
137. Khan NQ, Lees DM, Douthwaite JA, et al. Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (Lond). 2002;103:72s-75s.
138. Huang Y, Zhang A, Lau CW, et al. Vasorelaxant effects of purified green tea epicatechin derivatives in rat mesenteric artery. Life Sci. 1998; 63:275-283.
139. Lorenz M, Wessler S, Folmann E, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem. 2004;279:6190-6195.
140. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000;130(suppl 8S):2105S-2108S.
141. Anselm E, Socorro VF, Dal-Ros S, et al. Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src-And Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J Cardiovasc Pharmacol. 2009;53: 253-260.
142. Nanjo F, Mori M, Goto K, et al. Radical scavenging activity of tea catechins and their related compounds. Biosci Biotechnol Biochem. 1999;63:1621-1623.
143. Paquay JB, Haenen GR, Stender G, et al. Protection against nitric oxide toxicity by tea. J Agric Food Chem. 2000;48:5768-5772.
144. Ludwig A, Lorenz M, Grimbo N, et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun. 2004;316:659-665.
145. Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr. 2001;73:941-948.
146. Schewe T, Steffen Y, Sies H, How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys. 2008;476: 102-106.
147. Tang WJ, Hu CP, Chen MF, et al. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol. 2006;84:163-171.
148. Perez-Vizcaino F, Duarte J, Jiminez R, et al. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep. 2009;61:67-75.
149. Khoo NK, White CR, Pozzo-Miller L, et al. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med. 2010; 49:339-347.
150. Kuhlmann CR, S C, Kosok C, et al. Quercetin-induced induction of the NO/cGMP pathway depends on Ca2+-Activated K+ channel-induced hyperpolarization mediated Ca2+-entry into cultured human endothelial cells. Planta Med. 2005;71:520-524.
151. Andriantsitohaina R, Auger C, Chataigneau T, et al. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr. 2012;108:1532-1549.
152. Nicholson SK, Tucker GA, Brameld JM. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br J Nutr. 2010;103:1398-1403.
153. Traub O, Berk BC. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998;18:677-685.
154. El-Agamy DS, Nader MA. Attenuation of oxidative stress-induced vascular endothelial dysfunction by thymoquinone. Exp Biol Med (Maywood). 2012;237:1032-1038.
155. Bitis L, Kultur S, Melikoglu G, et al. Flavonoids and antioxidant activity of Rosa agrestis leaves. Nat Prod Res. 2010;24:580-589.
156. Pal R, Ariharasivakumar G, Girhepunjhe K, et al. In-vitro antioxidative activity of phenolic and flavonoids compounds extracted from seeds of Abrus precatorius. Int J Pharm Pharm Sci. 2009;1:136-140.
157. Gryglewski RJ, Korbut R, Robak J, et al. On the mechanism of anti thrombotic action of flavonoids. Biochem Pharmacol. 1987;36:317-322.
158. Lou FQ, Zhang MF, Zhang XG, et al. A study on tea pigment in prevention of atherosclerosis. Chin Med J (Engl). 1989;102:579-583.
159. Tapas AR, Sakarkar DM, Kakde RB. Flavonoids as nutraceuticals: A review. Trop J Pharm Res. 2008;7:1089-1099.
160. Alcaraz MJ, Ferrandiz ML. Modification of arachidonic metabolism by flavonoids. J Ethnopharmacol. 1987;21:209-229.